Optiver Holding’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$853 Sell
672
-512
-43% -$963 ﹤0.01% 2084
2025
Q4
$2.83K Hold
1,184
﹤0.01% 1790
2025
Q3
$3.37K Buy
+1,184
New +$4.05K ﹤0.01% 2096

Other funds holding HCAT

Optiver Holding's HCAT Position: Q1 2026 in Review

Optiver Holding reduced its Health Catalyst (HCAT) stake by 43% in Q1 2026, selling an estimated $963 and leaving 672 shares worth $853. The position accounts for ﹤0.01% of the portfolio, ranked #2084.

Optiver Holding first reported a position in HCAT in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.37K in Q3 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Optiver Holding held 672 shares of Health Catalyst worth $853 as of Q1 2026.
  • Optiver Holding sold 512 Health Catalyst shares in Q1 2026, an estimated $963.
  • Health Catalyst made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2084 holding.
  • Optiver Holding first reported a position in Health Catalyst in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Health Catalyst position peaked at $3.37K in Q3 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.